2025-08-08 21:10:00
Latest Post
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
RBI grants NBFC license to Equirus Group
Stock Report
Adarsh Mercantile Ltd Q2FY22 net profit at Rs. 13.68 lakhs
Posted On : 2021-11-10 20:08:39( TIMEZONE : IST )
has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 0.0504 crores during the period ended September 30, 2021 as compared to Rs. 0.0470 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 0.1368 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. -0.0056 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 0.37 for the period ended September 30, 2021 as compared to Rs. -0.02 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 0.0504 crs | ₹0.0470 crs |  7.23% |
| Net Profit | ₹0.1368 crs | ₹-0.0056 crs | 2,542.86% |
| EPS | ₹0.37 | ₹-0.02 | 1,950.00% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 0.0504 crores during the period ended September 30, 2021 as compared to Rs.0.0951 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.0.1368 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.0.1178 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.0.37 for the period ended September 30, 2021 as compared to Rs.0.32 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 0.0504 crs | ₹0.0951 crs |  -47.00% |
| Net Profit | ₹0.1368 crs | ₹0.1178 crs | 16.13% |
| EPS | ₹0.37 | ₹0.32 | 15.63% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.0.0974 crores during the 6 Months period ended September 30, 2021 as compared to Rs.0.1649 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.0.1312 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.0.2039 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.0.36 for the 6 Months period ended September 30, 2021 as compared to Rs.0.55 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹0.0974 crs | ₹0.1649 crs | -40.93% |
| Net Profit | ₹0.1312 crs | ₹0.2039 crs | -35.65% |
| EPS | ₹0.36 | ₹0.55 | -34.55% |
